This page will appear automatically.
Senescence and FOXO4-p53 interaction research. Included as a structured reference from the Aervyn peptide guide.
FOXO4-DRI is included in the guide under longevity & energy. The reference focuses on senescence and foxo4-p53 interaction research and distinguishes biological rationale from demonstrated outcomes.
An experimental D-retro-inverso peptide designed to disrupt FOXO4 and p53 interaction in senescent-cell models.
Grade D, early laboratory or animal information. Regulatory reference in the guide: research only. Evidence and legal status remain indication, product and market specific.
Findings for a named medicine, vial, nasal preparation, oral product or controlled trial does not automatically apply to an Aervyn pen. Long-term safety, formulation equivalence and individual response may remain uncertain.
Evidence, suitability, interactions and longer-term effects vary by compound. Product information is educational and is not a personal recommendation or administration protocol.
Published or handbook ranges do not establish individual suitability or directions.
Health conditions, medicines, allergies and monitoring needs require individual consideration.
Storage: Store refrigerated at 2 to 8°C, protected from light. Do not freeze. Follow the batch-specific label and handling information supplied with the product.
No. Reference amounts describe source-reported research context only, not a personal recommendation.
Grade D describes how much information is available, not whether FOXO4-DRI is right for you. See the evidence section above for detail.
Yes. Add it to your basket and submit an order request. No payment is taken at that point: we verify your details, then send a secure payment link by WhatsApp or email.
Contact our support team with the product name and batch reference and we'll help directly.
